Skip to content

Alpha Cognition ACOG Return on assets

Return on assets at other companies

Biogen logo
BiogenBIIB
4.9%-0.5pp
AbbVie logo
AbbVieABBV
2.7%-0.3pp
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-56.6%+15.0pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
27.4%+4.4pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
6.8%+5.6pp
uniQure logo
uniQureQURE
-30.2%-1.3pp

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+16.4%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Calculated from Alpha Cognition’s reported figures.

Based on trailing twelve months.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's return on assets?
Alpha Cognition (ACOG) reported return on assets of -42.7% in Q1 2026.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.